news_6

IRC Determines BRUKINSA® (Zanubrutinib) Demonstrates Superior Overall Response Rate Versus Ibrutinib in Final Response Analysis of ALPINE Trial in Chronic Lymphocytic Leukemia

news_6

DentalMonitoring, the Industry-leader in AI-powered Dental Software, Is Creating a New Business Unit, the DM Lab, as The Company Targets Continued Growth and Expansion

AUSTIN, Texas--(BUSINESS WIRE)--The purpose of the DM Lab will be to explore, test and validate business opportunities across the broad...